Thursday, January 25, 2018 9:47:35 AM
Shanghai Yunfeng Pharmaceutical and Canada Clever Pharma (Shanghai) strategic cooperation signing ceremony
On December 8, 2017, the signing ceremony of strategic cooperation between Shanghai Yunfeng Pharmaceutical Co., Ltd. and Smart Pharma (Shanghai) Co., Ltd. was held ceremoniously in the Sheshan Plant of Shanghai Yunfeng Pharmaceutical Co., Ltd.
Prior to the signing of the agreement, Ms. Yuan Aiping, chairman of Shanghai Yunfeng Pharmaceutical Co., Ltd. and Li Pengyu, general manager of Clever Pharma, held a meeting in which the two sides jointly recorded their friendship and looked forward to a good prospect of cooperation. They also talked about how to push forward the existing cooperation Project, further strengthening future cooperation in-depth exchange of views, reached a consensus.
Yuan Aiping, Chairman of Shanghai Yunfeng Pharmaceutical Co., Ltd., Lu Zhengde, General Manager, Xu Hongsheng, Sales Director, and Li Pengyu, General Manager of Clever Pharma, attended the signing ceremony on behalf of Dr. Ou Di Di, the chairman of Canada's smart pharmaceuticals.
The strategic cooperation signing ceremony, Shanghai Yunfeng Pharmaceutical and Smart Pharma established a new type of strategic cooperation between the two sides will conduct in-depth product development, marketing and other exchanges and cooperation in order to provide consumers with high-quality, high efficacy of drugs And strive to forge ahead.
Shanghai Yunfeng Pharmaceutical was founded in 1976, formerly known as Shanghai Yunfeng pharmaceutical factory, is approved by the Central Military Commission, the first batch of military enterprises. Company R & D, manufacturing, sales in one of the integration, research and development as the drive to the world for the Spirit, with great health responsibility, will create the vision of human health will always give top priority.
Smart Pharmaceutical (Shanghai) Co., Ltd. is an innovative pharmaceutical company recently founded in Shanghai by Dr Eudedi, Chairman of Smart Pharmaceuticals of Canada. The company will set up the largest R & D center for controlled and released drugs in Shanghai in China and will improve the influence and competitiveness of Chinese pharmaceutical enterprises in the world pharmaceutical market through constant preparation innovation.
The signing marks the establishment of a solid strategic partnership between the two parties and laid a good foundation for Shanghai Yunfeng to manufacture specialized pharmaceuticals and traditional Chinese medicine products. The heads of enterprises of both countries said that in the future, the two companies will conduct in-depth and comprehensive cooperation and join hands to shoulder the cause of human health so as to achieve a new situation of win-win cooperation.
Don't list Odidi as founder of smart pharma here
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM